ArticleBMJ open2019

Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.

Marnie Newell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.